Diagnostics can change the way payers and providers will respond to healthcare. Matching the patient with the right targeted therapy requires pharmaceutical and diagnostic companies to reach across industry lines and collaborate long before launch. They must understand the need create a strategy that enables the companion diagnostic to differentiate and accelerate the therapy rather than impede its growth.

Trust is the issue, given the small number of tandem launches. Both companies rely on trusty launch play books, failing to align efforts.

However, if the pharma partner evaluates and respects the rich arsenal of resources the diagnostics partner gets to the table, the pharma partner can leverage opportunities to differentiate products and help providers, patients and payers gain clarity in an increasingly complex market.

To know more…connect with your relationship manager or email us on engage@transactmedia.in